<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1112246396
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        UROMITEXAN 600 MG, film coated tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MESNA
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        600
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        280.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Temmler Pharma GmbH" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Temmler Pharma GmbH
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Deutschland GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        V03AF01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>Throughout this leaflet, Uromitexan 400 mg and 600 mg will be called <u>Mesna </u>Tablets.</strong></p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">Mesna Tablets contain a medicine called &lsquo;mesna&rsquo;.</p><p style="text-align:justify">Mesna Tablets are used to help reduce and prevent bleeding in the bladder (haemorrhagic cystitis) caused by cyclophosphamide and ifosfamide. Mesna Tablets help to protect the lining of the bladder from damage caused by these two drugs. The body breaks down these two drugs to form products that can harm the bladder. Mesna Tablets work by helping to make these breakdown products less harmful. Mesna Tablets should only be taken when you are also taking cyclophosphamide or ifosfamide.</p><p style="text-align:justify">The damage to your bladder may show up as blood in your urine.Very small amounts of blood may not be seen,so your doctor or nurse will test your urine with a&lsquo;dipstick&rsquo; or microscope to check for blood. If a larger amount of blood is in your urine,you will notice that it is red and very occasionally you may be able to see blood clots in it.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>You will not be given Mesna Tablets if:</strong></p><ul><li style="text-align:justify">you are allergic (hypersensitive) to Mesna or any of the other ingredients (listed in section 6).An allergic reaction can include shortness of breath,wheezing,rash,itching or swelling of the face and lips. If you are not sure if you are allergic talk to your doctor,nurse or pharmacist before having Mesna Tablets .</li></ul><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Warnings and precautions</strong></p><p style="text-align:justify">Talk to your doctor,nurse or pharmacist before you are given Mesna Tablets if:</p><ul><li style="text-align:justify">you have any problems with your immune systems called&lsquo;autoimmune&rsquo; disease,such as rheumatoid arthritis or lupus,where your body&rsquo;s immune system attacks itself. Patients with an autoimmune disease treated with cyclophosphamide and Mesna could have an increased risk of allergic (hypersensitivity) reactions.</li><li style="text-align:justify">you have experienced any side effects in the past when given a thiol-containing compound as there could be an increased risk of experiencing side-effects with Mesna. Examples of thiol-containing medicines are amifostine (used to reduce the toxicity of some chemotherapy products),penicillamine (used to treat rheumatoid arthritis) and captopril (used to treat hypertension or heart failure).</li></ul><p style="text-align:justify">If any of these applies to you your doctor will only give you Mesna following careful consideration of the risks and benefits to you.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Using other medicines</strong></p><p style="text-align:justify">Mesna Tablets is given with ifosfamide and cyclophosphamide. It does not react with these medicines,and is not known to react with any others.</p><p style="text-align:justify">However,always tell your doctor,nurse or pharmacist if you are taking or have recently taken any other medicines.This includes medicines you have obtained without a prescription.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Pregnancy, breast-feeding and fertility</strong></p><p style="text-align:justify">Mesna Tablets are only taken with ifosfamide and cyclophosphamide. If you are pregnant and your doctor thinks that you need treatment with these medicines,you will also need to have Mesna. Discuss pregnancy with your doctor before having this medicine.</p><p style="text-align:justify">Do not breast-feed while being treated with these medicines.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Tests while you are being given Mesna Tablets</strong></p><p style="text-align:justify">Mesna does not prevent the damage to the lining of the bladder in all patients.Your doctor or nurse will want to check your urine regularly for blood with a special&lsquo;dipstick&rsquo; or look at it under a microscope.</p><p style="text-align:justify">Tell your doctor,nurse or pharmacist if you are having any other urine tests because your medicines can affect the results.&lsquo;Dipstick&rsquo; and other types of tests frequently used to monitor diabetes can be used to detect&lsquo;ketones&rsquo; or Vitamin C levels in your urine. Mesna can interfere with these types of urine tests.</p><p style="text-align:justify">Mesna can also interfere with the results of certain laboratory tests for the creatine phosphokinase (CPK) enzyme.Your doctor or nurse are aware of this interference and different test methods will be used while you are receiving Mesna.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Mesna with food, drink and alcohol</strong></p><p style="text-align:justify">Food does not affect the absorption and urinary elimination of Mesna.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Driving and using machines</strong></p><p style="text-align:justify">Some of the side effects of treatment with Mesna might affect your ability to drive and use machines safely.Your doctor will decide if it is safe for you to do so.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Important information about some of the ingredients of Mesna Tablets</strong></p><p style="text-align:justify">This medicine contains lactose, which is a type of sugar. If you have ever been told by a doctor that you have an intolerance to some sugars, talk to your doctor before taking this medicine.<strong> </strong></p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>What to do if you see a different doctor, or have to go to hospital</strong></p><p style="text-align:justify">If you see any other doctor or have to go to hospital for any reason,tell them what medicines you are taking. Do not take any other medicines unless your doctor knows you are taking Mesna.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>Taking this medicine</strong></p><p style="text-align:justify">Take this medicine by mouth.</p><ul><li style="text-align:justify">You can take the tablets with or without food.</li><li style="text-align:justify">While you are taking Mesna Tablets you should drink enough fluid every day to maintain a urine output of 100 ml per hour.</li><li style="text-align:justify">This helps to dilute your urine and keeps a good</li><li style="text-align:justify">flow of urine. It will help to protect your bladder.<strong> </strong></li></ul><p style="text-align:justify">You should pass urine (empty your bladder) as normal when you need to. Do not try to change your usual pattern.</p><p style="text-align:justify"><strong>The recommended usual dose</strong></p><ul><li style="text-align:justify">Your doctor will decide how much of the medicine you will need and when you will need it. Always take the medicine exactly as your doctor tells you.</li><li style="text-align:justify">The dose will depend on:</li></ul><p style="margin-left:40px; text-align:justify">- the dose and timing of your treatment with ifosfamide or cyclophosphamide</p><p style="margin-left:40px; text-align:justify">- if ifosfamide or cyclophosphamide is being given to you as tablets or injection</p><p style="margin-left:40px; text-align:justify">- if you suffer from water infections (urinary tract infections)</p><p style="margin-left:40px; text-align:justify">- if you have ever had signs of bladder damage from Ifosfamide or Cyclophosphamide before</p><p style="margin-left:40px; text-align:justify">- if you have had radiation therapy near your bladder.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Use in children</strong></p><p style="text-align:justify">Children generally urinate more frequently than adults. For children your doctor may need to shorten the interval between doses and/or increase the number of individual doses.</p><p style="text-align:justify"><strong>If you are not sure how you will be given your injection or when you should drink it, ask your doctor, nurse or pharmacist.</strong></p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>If you take more Mesna Tablets than you should</strong></p><p style="text-align:justify">If you take too many tablets, or if a child has swallowed any of your tablets, talk to a doctor or go to a hospital straight away. Always take the labelled medicine container with you whether or not there is any medicine left.</p><p style="text-align:justify">Taking too much of Mesna can cause symptoms such as nausea, vomiting, abdominal pain, diarrhoea, headache, fatigue, limb and joint pains, rash, flushing, low blood pressure, slow or irregular heartbeat, feeling of pins and needles like tingling, fever, and breathing difficulties.</p><p style="text-align:justify">A specific antidote treatment for Mesna overdose is not known.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>If you forget to take Mesna Tablets</strong></p><p style="text-align:justify">It is very important to have Mesna Tablets at the times your doctor has told you:</p><ul><li style="text-align:justify">these times will have been carefully worked out to make sure that your bladder is fully protected against damage.</li></ul><p style="text-align:justify">If you do forget to take your tablets, take them as soon as you remember, and talk to your doctor or go to your nearest hospital immediately for advice.</p><p style="text-align:justify">If you have any further questions on the use of this medicine,ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Like all medicines,this medicine can cause side effects,although not everybody gets them.</p><p style="text-align:justify">Some of these side effects may be caused by cyclophosphamide or ifosfamide rather than Mesna,as they are always taken together.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Tell your doctor straight away, if you notice any of the following side effects, you may need urgent medical attention: </strong></p><ul><li style="text-align:justify">The most severe adverse reactions associated with use of Mesna are:</li></ul><p style="margin-left:40px; text-align:justify">o Anaphylaxis. Signs of this would be shortness of breath,wheezing,rash, itching or swelling of the face and lips (hypersensitivity). Severe allergic reactions could lead to difficulty in breathing or shock,with a possible fatal outcome (anaphylactic shock, anaphylactic/anaphylactoid reaction).</p><p style="margin-left:40px; text-align:justify">o Bullous skin reactions which are life threatening conditions which cause:</p><p style="margin-left:40px; text-align:justify; text-indent:50px">-&nbsp;rash,</p><p style="margin-left:40px; text-align:justify; text-indent:50px">-&nbsp;ulcers,</p><p style="margin-left:40px; text-align:justify; text-indent:50px">-&nbsp;sore throat,</p><p style="margin-left:40px; text-align:justify; text-indent:50px">-&nbsp;fever,</p><p style="margin-left:40px; text-align:justify; text-indent:50px">- conjunctivitis,</p><p style="margin-left:40px; text-align:justify; text-indent:50px">-&nbsp;blistering of the skin.</p><p style="margin-left:40px; text-align:justify">o Drug rash with eosinophilia and systemic symptoms (DRESS) which is a life threatening hypersensitivity reaction to drugs which can cause:</p><p style="margin-left:80px; text-align:justify">-&nbsp;rash,</p><p style="margin-left:80px; text-align:justify">- fever,</p><p style="margin-left:80px; text-align:justify">-&nbsp;pain and swelling of internal organs,</p><p style="margin-left:80px; text-align:justify">&ndash; swollen and tender lymph nodes,</p><p style="margin-left:80px; text-align:justify">- changes in blood cells (eosinophilia).</p><ul><li style="text-align:justify">The most frequently occurring adverse reactions associated with use of Mesna,are:</li></ul><p style="margin-left:40px; text-align:justify">o&nbsp;feeling sick,headache,diarrhoea,</p><p style="margin-left:40px; text-align:justify">o&nbsp;fever,flushing,rash,</p><p style="margin-left:40px; text-align:justify">o infusion site reactions such as pain, swelling,itching,redness or rash around the injection site,</p><p style="margin-left:40px; text-align:justify">o&nbsp;waves of sudden abdomen or stomach pain (colic),</p><p style="margin-left:40px; text-align:justify">o&nbsp;light headedness,lack of energy, tiredness,</p><p style="margin-left:40px; text-align:justify">o&nbsp;flu-like illness.</p><p style="text-align:justify">If you are actually sick (vomit) after taking Mesna as a drink,you may need to have Mesna by injection instead.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Other possible side effects include:</strong></p><p style="text-align:justify">Blood and Lymphatic System</p><ul><li style="text-align:justify">swollen/enlarged lymph nodes (lymphadenopathy).</li></ul><p style="text-align:justify">Metabolism and Nutrition</p><ul><li style="text-align:justify">decreased appetite,</li><li style="text-align:justify">feeling dehydrated.</li></ul><p style="text-align:justify">Psychiatric</p><ul><li style="text-align:justify">insomnia,</li><li style="text-align:justify">nightmares.</li></ul><p style="text-align:justify">Nervous System</p><ul><li style="text-align:justify">dizziness,</li><li style="text-align:justify">fainting (syncope),</li><li style="text-align:justify">sensation of tickling,tingling,burning, pricking (paresthesia),</li><li style="text-align:justify">increased or abnormally painful sensitivity to touch (hyperesthesia),</li><li style="text-align:justify">reduced sensitivity to touch (hypoesthesia),</li><li style="text-align:justify">disturbance in paying attention.</li></ul><p style="text-align:justify">Eyes</p><ul><li style="text-align:justify">blurred sight,</li><li style="text-align:justify">sensitivity to light,</li><li style="text-align:justify">inflammation of the eye (conjunctivitis).</li></ul><p style="text-align:justify">Heart and Circulation</p><ul><li style="text-align:justify">changes in your heartbeat (palpitation),</li><li style="text-align:justify">faster heart beat (tachycardia),</li><li style="text-align:justify">low blood pressure (hypotension).</li></ul><p style="text-align:justify">Lungs</p><ul><li style="text-align:justify">nasal congestion,</li><li style="text-align:justify">cough,</li><li style="text-align:justify">severe,sharp pain when breathing in (pleuritic pain),</li><li style="text-align:justify">dry mouth,</li><li style="text-align:justify">difficulty in breathing or wheezing (bronchospasm),</li><li style="text-align:justify">shortness of breath (dyspnea),</li><li style="text-align:justify">vocal cord discomfort (laryngeal discomfort),</li><li style="text-align:justify">nosebleeds (epistaxis),</li><li style="text-align:justify">severe difficulty breathing (respiratory distress),</li><li style="text-align:justify">decrease levels of oxygen in your body (hypoxia).</li></ul><p style="text-align:justify">Digestive system</p><ul><li style="text-align:justify">irritation of the lining of the mouth and digestive system (mucosal irritation),</li><li style="text-align:justify">flatulence,</li><li style="text-align:justify">burning pain in the area of the stomach, &bull; constipation,</li><li style="text-align:justify">bleeding gums.</li></ul><p style="text-align:justify">Liver</p><ul><li style="text-align:justify">increased levels of certain proteins produced by your liver called enzymes (increased transaminases).Your doctor will do blood tests to test for these.</li></ul><p style="text-align:justify">Skin and SubcutaneousTissue</p><ul><li style="text-align:justify">itching (pruritus),</li><li style="text-align:justify">excessive sweating (hyperhidrosis),</li><li style="text-align:justify">itchy,red rash which can develop in to sores (erythema multiforme,erythema),</li><li style="text-align:justify">ulceration or blistering,</li><li style="text-align:justify">swelling of the deeper layers of the skin,caused by a build-up of fluid (angioedema),</li><li style="text-align:justify">skin rash notable for pale red,raised, itchy bumps (urticaria),</li><li style="text-align:justify">burning sensation.</li></ul><p style="text-align:justify">Musculoskeletal and ConnectiveTissue</p><ul><li style="text-align:justify">muscle or joint pain (myalgia,arthralgia),</li><li style="text-align:justify">back pain,</li><li style="text-align:justify">pain in hands or feet (pain in extremity),</li><li style="text-align:justify">jaw pain.</li></ul><p style="text-align:justify">Renal and Urinary</p><ul><li style="text-align:justify">painful urination (dysuria),</li><li style="text-align:justify">kidney failure (acute renal failure).</li></ul><p style="text-align:justify">General Disorders andAdministrative Site Conditions</p><ul><li style="text-align:justify">chills (rigors),</li><li style="text-align:justify">chest pain,</li><li style="text-align:justify">swelling of the face (face oedema),</li><li style="text-align:justify">swelling of tissues,usually in the lower limbs,due to the accumulation of fluids (oedema peripheral),</li><li style="text-align:justify">muscle weakness (Asthenia).</li></ul><p style="text-align:justify">If you get any side effects,talk to your doctor, nurse or pharmacist.This includes any possible side effects not listed in this leaflet.You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>To report any side effect(s):</strong></p><ul><li style="text-align:justify"><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa&nbsp;</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc&nbsp;</p></td></tr></tbody></table><p style="text-align:justify">&nbsp;</p><ul><li style="text-align:justify"><strong>Other GCC States:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td><p style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table><p style="text-align:justify">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the label after EXP.The expiry date refers to the last day of that month.</p><p>Do not store above 30&ordm;C</p><p>Medicines should not be disposed of via wastewater or household waste. If you have some Mesna in a drink left over,take them back to your hospital.These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is mesna and each filmcoated tablet contains 400 mg or 600 mg.</p><p>The other ingredients are: lactose monohydrate, microcrystalline cellulose, dibasic calcium phosphate dehydrate, corn starch, povidone K25, magnesium stearate, hydroxypropylmethylcellulose, polyethylene glycol 6000, titanium dioxide (E 171), simethicone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The tablets are white and oblong with a notch on one side and either M4 or M6 on the other. They are available in blister strips in cartons containing 10, 20 and 50 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The MarketingAuthorisation holder is: </strong></p><p><strong>Baxter Oncology GmbH </strong></p><p>Kantstrasse 2</p><p>33790 Halle/Westfalen</p><p>Germany</p><p>&nbsp;</p><p><strong>Mesna is manufactured by: </strong></p><p><strong>Temmler Pharma GmbH &amp; Co. KG</strong></p><p>Temmlerstrasse 2&nbsp;</p><p>35039 Marburg</p><p>Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                October 2014
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="text-align:justify"><strong>سيتم الإشارة إلى أقراص يوروميتيكسان 400 ملجم و 600 ملجم في هذه النشرة بأقراص <u>ميسنا</u>.</strong></p><p dir="RTL" style="text-align:justify">تحتوي أقراص ميسنا على دواء يسمى &quot;ميسنا&quot;.</p><p dir="RTL" style="text-align:justify">تستخدم أقراص ميسنا للمساعدة في تقليل ومنع النزيف في المثانة (التهاب المثانة النزفي) الناتج عن السيكلوفوسفاميد&rlm;‫ والايفوسفامايد&rlm;‫&rlm;‫. تساعد أقراص ميسنا على حماية بطانة المثانة من الضرر الناتج عن هذين العقارين، حيث يقوم الجسم بتحليل هذين العقارين وتكوين منتجات تضر بالمثانة. يتلخص عمل أقراص ميسنا في أنها تجعل هذه المنتجات الناتجة أقل ضررًا. يجب فقط تناول أقراص ميسنا في حالة تناولك للسيكلوفوسفاميد&rlm;‫ أو الايفوسفامايد&rlm;‫&rlm;‫.</p><p dir="RTL" style="text-align:justify">إن وجود دم في البول ربما يكون علامة على تضرر المثانة. قد لا يمكن رؤية كميات الدم الصغيرة للغاية بالعين المجردة، لذلك سيقوم الطبيب أو الممرض بعمل اختبار بول باستخدام &quot;غميسة&quot; أو مجهر للتحقق من وجود دم. في حال وجود كمية كبيرة من الدم في البول فستلاحظ أن لونه أحمر وفي بعض الأحيان ستتمكن من رؤية كتل دم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify"><strong>لا تتناول أقراص ميسنا:</strong></p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تُعاني من حساسية لميسنا أو أي من المكونات الأخرى (المدرجة في القسم 6). تتضمن أعراض الإصابة بحساسية ضيق التنفس أو أزيز أو طفح جلدي أو حكة أو تورم الوجه والشفتين. إذا لم تكن متأكدًا من أنك تعاني من حساسية، فاستشر طبيبك أو الممرض أو الصيدلاني قبل تناول أقراص ميسنا.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL" style="text-align:justify">تحدّث إلى طبيبك أو الممرض أو الصيدلاني قبل استخدام أقراص ميسنا إذا:</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مشكلات في جهاز المناعة تسمى &quot;أمراض المناعة الذاتية&quot; مثل التهاب المفاصل الروماتويدي أو الذئبة، وفيها يقوم جهاز المناعة في الجسم بمهاجمة نفسه. إن المرضى المصابين بأحد أمراض المناعة الذاتية ويتم معالجتهم بالسيكلوفوسفاميد&rlm;‫ وميسنا يكونون أكثر عرضة للإصابة بتفاعلات تحسسية (فرط الحساسية).</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;كنت قد عانيت من آثار جانبية في الماضي عند تناولك لمركب يحتوي على ثيول، حيث قد تكون بذلك أكثر عرضة للإصابة بالآثار الجانبية الخاصة بميسنا. من أمثلة الأدوية المحتوية على ثيول الأميفوستين (يُستخدم لتقليل سمية بعض المواد المنتجة عن العلاج الكيميائي) والبنسيلامين (يُستخدم في علاج التهاب المفاصل الروماتويدي) والكابتوبريل (يُستخدم في علاج ضغط الدم المرتفع وقصور القلب).</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify">إذا كان ينطبق عليك أيًا من ذلك، سيقوم الطبيب بإعطائك ميسنا بعد التفكير في المخاطر والفوائد بتأن.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>استخدام أدوية أخرى</strong></p><p dir="RTL" style="text-align:justify">يتم تناول أقراص ميسنا مع السيكلوفوسفاميد&rlm;‫ والايفوسفامايد. فهي لا تتفاعل مع هذه الأدوية، وليس من المعروف أنها تتفاعل مع أي أدوية أخرى.</p><p dir="RTL" style="text-align:justify">ومع ذلك، قم بإخبار الطبيب أو الممرض أو الصيدلاني دائمًا إذا كنت تستخدم أي أدوية أخرى أو استخدمتها مؤخرًا. بما في ذلك الأدوية التي حصلت عليها دون وصفة طبية.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL" style="text-align:justify">تؤخذ أقراص ميسنا مع السيكلوفوسفاميد&rlm;‫ والايفوسفامايد فقط. إذا كنتِ حاملاً أو ترضعين رضاعة طبيعية واعتقد طبيبكِ أنه يجب معالجتكِ بهذه الأدوية، فستحتاجين بالتالي إلى ميسنا.</p><p dir="RTL" style="text-align:justify">ناقشي الحمل مع طبيبكِ قبل استخدام هذا الدواء.</p><p dir="RTL" style="text-align:justify">لا ترضعين رضاعة طبيعية أثناء استخدامك هذه الأدوية.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>الاختبارات التي يتم إجراؤها أثناء استخدام أقراص ميسنا</strong></p><p dir="RTL" style="text-align:justify">لا تقي أقراص ميسنا من تضرر بطانة المثانة عند جميع المرضى. سيقوم الطبيب أو الممرض بفحص البول بصورة منتظمة للتحقق من وجود دم باستخدام &quot;غميسة&quot; خاصة أو بفحص العينة تحت المجهر.</p><p dir="RTL" style="text-align:justify">أخبر الطبيب أو الممرض أو الصيدلاني إذا كنت ستقوم بإجراء أي اختبارات بول أخرى نظرًا لأن أدويتك قد تؤثر على النتائج. يتم استخدام اختبار &quot;الغميسة&quot; وأنواع أخرى من الاختبارات المستعملة لمتابعة مرض السكري لاكتشاف &quot;الكيتونات&quot; أو مستويات فيتامين ج في البول. ويؤثر ميسنا على هذه الأنواع من اختبارات البول.</p><p dir="RTL" style="text-align:justify">كذلك يتداخل ميسنا مع نتائج اختبارات الدم المعملية لإنزيم فسفوكيناز الكرياتين (CPK). يكون طبيبك أو الممرض على دراية بهذا التدخل وسيتم استخدام طرق أخرى لإجراء الاختبارات أثناء تناولك لميسنا.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>استخدام ميسنا مع الأطعمة والمشروبات والكحوليات</strong></p><p dir="RTL" style="text-align:justify">لا يؤثر الطعام في امتصاص ميسنا وخروجه من الجسم عبر البول.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>قيادة السيارة واستخدام الآلات</strong></p><p dir="RTL" style="text-align:justify">قد تؤثر بعض الآثار الجانبية للعلاج بميسنا على قدرتك على القيادة واستخدام الآلات بأمان. سيقرر طبيبك مدى أمان قيامك بهذا.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>معلومات مهمة حول بعض مكونات أقراص ميسنا</strong></p><p dir="RTL" style="text-align:justify">يحتوي هذا الدواء على اللاكتوز، وهو نوع من أنواع السكر. إذا أخبرك أحد الأطباء</p><p dir="RTL" style="text-align:justify">بأنك تعاني من عدم القدرة على تحمل بعض أنواع السكر، فتحدث إلى طبيبك المعالج قبل استخدام هذا الدواء.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>ما عليك فعله إذا بدأت في استشارة طبيب آخر أو اضطررت للذهاب إلى المستشفى</strong></p><p dir="RTL" style="text-align:justify">إذا بدأت في استشارة طبيب آخر أو ذهبت إلى المستشفى لأي سبب، أخبرهم بالأدوية التي تستخدمها. لا تستخدم أي أدوية أخرى إلا إذا كان طبيبك المعالج على دراية بأنك تتناول ميسنا.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p style="text-align:justify">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify"><strong>تناول هذا الدواء</strong></p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول هذا الدواء عن طريق الفم.</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكنك تناول الأقراص مع طعام أو دونه.</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلال الفترة التي تتناول فيها أقراص ميسنا يجب عليك تناول كميات كافية من السوائل بصورة يومية للحفاظ على مقدار البول الذي تخرجه عند 100 مل في الساعة.</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يساعد هذا على تخفيف البول والمحافظة على تدفق بول جيد. كما يساعد على حماية مثانتك.</p><p dir="RTL" style="text-align:justify">يمكنك التبول (إفراغ مثانتك) كلما احتاجت بصورة طبيعية، فلا تحاول تغيير نمطك المعتاد.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>الجرعة المعتادة الموصى بها</strong></p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيقرر طبيبك المعالج المقدار المطلوب من الدواء ومواعيد تناوله. تناول الدواء دائمًا حسب إرشادات الطبيب بالضبط.</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ستعتمد الجرعة المقررة على:</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جرعة السيكلوفوسفاميد&rlm;‫ والايفوسفامايد التي تستخدمها ومواعيدها</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستخدم السيكلوفوسفاميد&rlm;‫ والايفوسفامايد في هيئة أقراص أم حقن</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بعدوى في السبيل البولي</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا ظهرت لديك من قبل علامات على حدوث تضرر في المثانة ناتج عن السيكلوفوسفاميد&rlm;‫ أو الايفوسفامايد</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا خضعت للعلاج الإشعاعي على منطقة قريبة من المثانة</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>الاستخدام مع الأطفال</strong></p><p dir="RTL" style="text-align:justify">بصورة عامة، يتبول الأطفال بصورة متكررة عن البالغين. عند وصف الطبيب الدواء للأطفال فقد يقوم بتقصير المدة بين الجرعات أو زيادة عدد الجرعات الفردية.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>إذا ساورك شك بشأن كيفية تناول الأقراص، فاستشر طبيبك أو الممرض أو الصيدلاني.</strong></p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>في حالة تناول جرعة مفرطة من أقراص ميسنا</strong></p><p dir="RTL" style="text-align:justify">إذا تناولت الكثير من الأقراص أو ابتلع طفلك أيًا من أقراصك، فاستشر الطبيب أو اذهب إلى المستشفى على الفور. أحضِر عبوة الدواء التي تحمل اسمه معك سواء كان هناك دواء متبقي أم لا.</p><p dir="RTL" style="text-align:justify">إن تناول جرعة مفرطة من ميسنا قد يتسبب في أعراض مثل الغثيان والقيء وألم في البطن وإسهال وصداع والتعب وألم في المفاصل والأطراف وطفح جلدي وإحمرار وانخفاض ضغط الدم وضربات قلب بطيئة أو غير منتظمة والشعور بالنخر أو الوخز والحمى وصعوبات في التنفس.</p><p dir="RTL" style="text-align:justify">لا يوجد ترياق معروف لعلاج حالات تناول جرعات مفرطة من ميسنا.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>إذا نسيت تناول أقراص ميسنا:</strong></p><p dir="RTL" style="text-align:justify">إن تناول أقراص ميسنا في الأوقات التي أخبرك الطبيب بها هو أمرًا في غاية الأهمية:</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حيث أن هذه الأوقات تم تحديدها بعناية لضمان حماية مثانتك من التعرض للضرر.</p><p dir="RTL" style="text-align:justify">إذا نسيت تناول الدواء، فتناوله على الفور وقتما تتذكر واستشر طبيبك المعالج أو اذهب إلى أقرب مستشفى على الفور لتلقي النصيحة.</p><p dir="RTL" style="text-align:justify">إذا كانت لديك المزيد من الاستفسارات حول استخدام هذا الدواء، فاسأل طبيبك أو الصيدلاني أو الممرض.</p><p style="text-align:justify">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">&rlm;‫قد يتسبب هذا الدواء في حدوث آثار جانبية، كغيره من الأدوية، ولكن ليس بالضرورة أن تحدث هذه الآثار للجميع.</p><p dir="RTL" style="text-align:justify">قد تنتج بعض هذه الآثار الجانبية عن السيكلوفوسفاميد&rlm;‫ أو الايفوسفامايد وليس عن ميسنا، حيث أنه يتم استخدامهما معًا دائمًا.</p><p dir="RTL" style="text-align:justify"><strong>أخبر طبيبك على الفور إذا لاحظت أيًا من الآثار الجانبية التالية، حيث قد تحتاج إلى رعاية طبية ملحة:</strong></p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التفاعلات الضارة الأكثر شدة المتعلقة باستخدام ميسنا هي:</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأق. تتضمن أعراضه ضيق التنفس وأزيز وطفح جلدي وحكة وتورم الوجه والشفتين (فرط الحساسية). قد تتسبب التفاعلات التحسسية الحادة في صعوبة في التنفس أو الصدمة مما قد يؤدي إلى عواقب مهددة للحياة (صدمة تأقية، تفاعل تأقي/تأقاني).</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات جلدية فقاعية، وهي حالات مهددة للحياة وتتسبب في:</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; طفح جلدي</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; قرحات</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; التهاب الحلق</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; حمى</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; التهاب الملتحمة</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; نفط الجلد</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح دوائي مصاحب لكثرة اليوزينيات والأعراض المجموعية (DRESS) وهو أحد تفاعلات الحساسية المفرطة المهددة للحياة للأدوية والذي قد يتسبب في:</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; طفح جلدي</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; حمى</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; ألم وتورم الأعضاء الداخلية</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; تورم العقد اللمفاوية والشعور بألم فيها</p><p dir="RTL" style="text-align:justify">&ndash;&nbsp; تغييرات في خلايا الدم (كثرة اليوزينيات)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التفاعلات الضارة الأكثر شيوعًا المتعلقة باستخدام ميسنا هي:</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالإعياء، صداع، إسهال</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى، إحمرار، طفح جلدي</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بألم مفاجئ في البطن أو المعدة (القولون)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار، قلة نشاط، إرهاق</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض مشابهة للإنفلونزا</p><p dir="RTL" style="text-align:justify">إذا تقيئت بالفعل بعد تناول أقراص ميسنا، فقد تحتاج إلى تناول ميسنا عن طريق الحقن بدلاً من ذلك.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>تتضمن الآثار الجانبية الأخرى المحتملة:</strong></p><p dir="RTL" style="text-align:justify">الدم والجهاز اللمفي</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم/تضخم العقد اللمفاوية</p><p dir="RTL" style="text-align:justify">التمثيل الغذائي والتغذية</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف الشهية</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالجفاف</p><p dir="RTL" style="text-align:justify">الناحية النفسية</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأرق</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كوابيس</p><p dir="RTL" style="text-align:justify">العصبي المركزي</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إغماء (الغشي)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالنخر أو الحرقان أو الوخز (المذل)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية للمس متزايدة أو مؤلمة بصورة غير معتادة (فرط الحس)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية أقل للمس (نقص الحس)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في الانتباه</p><p dir="RTL" style="text-align:justify">العيون</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رؤية غير واضحة</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية للضوء</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب في العينين (التهاب الملتحمة)</p><p dir="RTL" style="text-align:justify">القلب والدورة الدموية</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بأنك تعاني من خفقان القلب</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضربات قلب سريعة (تسرع القلب)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم</p><p dir="RTL" style="text-align:justify">الرئة</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتقان الأنف</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سعال</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم حاد عند الشهيق (التهاب الجنبة)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس أو أزيز (التشنج القصبي)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس (زلة)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنزعاج في الأحبال الصوتية (إنزعاج في الحنجرة)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف أنفي (رُعاف)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة شديدة في التنفس (ضائقة تنفسية)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات منخفضة من الأكسجين في الجسم (نقص التأكسج)</p><p dir="RTL" style="text-align:justify">الجهاز الهضمي</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تهيج بطانة الفم والجهاز الهضمي (تهيج الأغشية المخاطية)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ البطن</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم حارق في منطقة المعدة</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إمساك</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف في اللثة</p><p dir="RTL" style="text-align:justify">الكبد</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات متزايدة من بروتينات معينة التي ينتجها الكبد تسمى إنزيمات (تزايد ناقلات الأمينات). سيقوم طبيبك بإجراء اختبارات دم للتحقق من وجود هذه الإنزيمات.</p><p dir="RTL" style="text-align:justify">الجلد والأنسجة تحت الجلد</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعرق مفرط (فرط التعرق)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أحمر مسبب للحكة التي قد تتفاقم إلى قرحات (حُمامي عديدة الأشكال، حُمامي)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقرحات أو تنفط</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الطبقات العميقة من الجلد، ناتج عن تجمع السوائل (الوذمة الوعائية)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي يتميز بتحاديب مرتفعة ذات لون أحمر شاحب ومسبب للحكة</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بحرقان</p><p dir="RTL" style="text-align:justify">الجهاز العضلي الهيكلي والأنسجة الضامة</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في العضلات أو المفاصل (ألم عضلي، ألم مفصلي)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الظهر</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في اليدين أو القدمين (ألم في الأطراف)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الفك</p><p dir="RTL" style="text-align:justify">الجهاز الكلوي والبولي</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم عند التبول (عسر التبول)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل كلوي (فشل كلوي حاد)</p><p dir="RTL" style="text-align:justify">&rlm;‫اضطرابات عامة وحالات موقع الإعطاء</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتجافات الجسم (نافض)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالصدر</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه (وذمة الوجه)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم أنسجة الجسم، عادة في الأطراف السفلية، نتيجة تجمع السوائل (الوذمة الطرفية)</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف العضلات (وهن)</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify">في حالة تعرضك لأي آثار جانبية، تحدث إلى طبيبك الخاص أو الممرض أو الصيدلاني. يشمل هذا أي آثار جانبية محتملة غير واردة في هذه النشرة. كما يمكنك الإبلاغ بالآثار الجانبية مباشرة (انظر التفاصيل أدناه). بالإبلاغ عن الآثار الجانبية يمكنك المساعدة في توفير مزيد من المعلومات بشأن سلامة هذا الدواء.</p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>للإبلاغ عن الآثار الجانبية:</strong></p><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>&middot;&nbsp; &nbsp; المملكة العربية&nbsp;</strong><strong>السعودية</strong>:</p><p dir="RTL" style="text-align:justify">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td style="vertical-align:top"><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس: +966-11-205-7662</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتصل بالمركز على +966-11-2038222، رقم داخلي: 2317-2356-2353-2354-2334-2340.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رقم الهاتف المجاني: 8002490000</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موقع الويب: www.sfda.gov.sa/npc</p><p dir="RTL" style="text-align:justify">&nbsp;</p></td></tr></tbody></table><p dir="RTL" style="text-align:justify">&nbsp;</p><p dir="RTL" style="text-align:justify"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى</strong>:</p><p dir="RTL" style="text-align:justify">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td><p dir="RTL" style="text-align:justify">-&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالهيئة المختصة.</p></td></tr></tbody></table><p style="text-align:justify">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">يحفظ بعيدًا عن متناول ورؤية الأطفال.</p><p dir="RTL" style="text-align:justify">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على الغلاف بعد EXP.</p><p dir="RTL" style="text-align:justify">يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</p><p dir="RTL" style="text-align:justify">يجب عدم التخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية. إذا كان متبقي لديك بعض الأقراص فأعدها إلى المستشفى. تساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL" style="text-align:justify">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify"><strong>مكونات أقراص ميسنا</strong></p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن المادة الفعالة في هذا الدواء هي ميسنا ويحتوي كل قرص مغلف على 400 ملجم أو 600 ملجم منها.</p><p dir="RTL" style="text-align:justify">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وتكون المكونات الأخرى للمنتج كالتالي: أحادي هيدرات اللاكتوز، سليلوز دقيق التبلور، ثنائي هيدرات فوسفات الكالسيوم ثنائية القاعدة، نشا الذرة، بوفيدون K25، سترات المغنيزيوم، هيدروكسي بروبيل ميثيل سليلوز، جليكول البولي إثيلين 6000، ثاني أكسيد التيتانيوم (E 171)، سيميثيكون.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify"><strong>كيف تبدو أقراص ميسنا وما محتويات العبوة</strong></p><p dir="RTL" style="text-align:justify">الأقراص بيضاء ومستطيلة، ويوجد خط على وجه والوجه الآخر عليه M4 أو M6. وهي متوفرة في شرائط معدنية فقاعية في علب كرتونية تحتوي على 10 أو 20 أو 50 قرص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>حامل ترخيص التسويق:</strong></p><p dir="RTL"><strong>Baxter Oncology GmbH</strong></p><p dir="RTL">Kantstrasse 2</p><p dir="RTL">33790 Halle/Westfalen</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المصنع:</strong></p><p><strong>Temmler Pharma GmbH &amp; Co. KG</strong></p><p>Temmlerstrasse 2&nbsp;</p><p>35039 Marburg</p><p>Germany</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يوليو 2014
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Uromitexan Tablets 600 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Uromitexan film-coated tablets: 600 mg as the active ingredient “Mesna”
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets for oral use
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">For the prevention of urothelial toxicity including haemorrhagic cystitis, microhaematuria and macrohaematuria in patients treated with ifosfamide and cyclophosphamide, in doses considered to be urotoxic.</p><p style="text-align:justify">&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Sufficient Mesna must be given to adequately protect the patient from the urotoxic effects of the oxazaphosphorine.</p><p style="text-align:justify">The duration of Mesna treatment should equal that of the oxazaphosphorine treatment plus the time taken for the urinary concentration of oxazaphosphorine metabolites to fall to non-toxic levels. This usually occurs within 8-12 hours after the end of oxazaphosphorine treatment but may vary depending on the scheduling of oxazaphosphorine. When calculating the dose of Mesna the quantity should be rounded down to the nearest whole tablet. Urinary output should be maintained at 100 ml/hr (as required for oxazaphosphorine treatment) and the urine monitored for haematuria and proteinuria throughout the treatment period.</p><p style="text-align:justify">Compared with intravenous administration, overall availability of Mesna in urine after oral administration is approximately 50%; and the onset of urinary excretion is delayed by up to 2 hours and is more prolonged than following intravenous dosing.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>F</u><u>or intermittent oxazaphosphorine therapy</u></p><p style="text-align:justify">Oral administration of 40% of the dosage of the oxazaphosphorine on a weight for weight basis rounded down to the nearest whole tablet. The oral dose of Mesna should be taken 2 hours before and at 2 hours and 6 hours after oxazaphosphorine dosing.</p><p style="text-align:justify">If the Mesna is to be administered intravenously in the first instance, the oral administration at -2 hours should be replaced by the i.v. at 0 hours.</p><p style="text-align:justify">Example dosage schedule:</p><table border="1" align="center" cellspacing="5" cellpadding="5" style="width:500px"><tbody><tr><td style="text-align:center">&nbsp;</td><td><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:center">-2 hrs</p></td><td style="text-align:center; vertical-align:top">&nbsp;</td></tr></tbody></table></td><td style="text-align:center">0 hrs</td><td style="text-align:center">2 hrs</td><td style="text-align:center">6 hrs</td></tr><tr><td style="text-align:center">Cyclophosphamide/ Ifosfamide</td><td style="text-align:center">-</td><td style="text-align:center">1 g iv</td><td style="text-align:center">-</td><td style="text-align:center">-</td></tr><tr><td style="text-align:center">Mesna</td><td style="text-align:center">400 mg po</td><td style="text-align:center">-</td><td style="text-align:center">400 mg po</td><td style="text-align:center">400 mg po</td></tr><tr><td style="text-align:center">&nbsp;</td><td style="text-align:center">-</td><td style="text-align:center">200 mg iv</td><td style="text-align:center">400 mg po</td><td style="text-align:center">400 mg po</td></tr></tbody></table><p style="text-align:center">&nbsp;</p><p style="text-align:justify"><u>W</u><u>here ifosfamide is used as a 24 hour infusion</u></p><p style="text-align:justify">Oral Mesna should be taken as the combined infusion of ifosfamide and Mesna finishes. Then at 2 hours and 6 hours after the time at the finish of the infusion. All doses are 40% (w/w) of the ifosfamide dose rounded down to the nearest whole tablet.</p><p style="text-align:justify">Example dosage schedule:</p><table border="1" align="center" cellspacing="5" cellpadding="5" style="width:582px"><tbody><tr><td style="text-align:center">&nbsp;</td><td><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><table border="0" cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top">0 hrs</td></tr></tbody></table></td><td style="text-align:center; vertical-align:top">&nbsp;</td></tr></tbody></table></td><td style="text-align:center">0-24 hrs</td><td style="text-align:center">24 hrs</td><td style="text-align:center">26 hrs</td><td style="text-align:center; width:80px">30 hrs</td></tr><tr><td style="text-align:center">Ifosfamide</td><td style="text-align:center">-</td><td style="text-align:center">5g/m&sup2; infusion</td><td style="text-align:center">-</td><td style="text-align:center">-</td><td style="text-align:center; width:80px">-</td></tr><tr><td style="text-align:center">Mesna</td><td style="text-align:center">1 g/m&sup2; iv</td><td style="text-align:center">5g/m&sup2; infusion</td><td style="text-align:center">2g/m&sup2; po</td><td style="text-align:center">2g/m&sup2; po</td><td style="text-align:center; width:80px">2g/m&sup2; po</td></tr></tbody></table><p>&nbsp;</p><p style="text-align:justify"><u>W</u><u>here ifosfamide is used as a long-term continuous infusion</u></p><p style="text-align:justify">Oral Mesna should be taken as the combined infusion of ifosfamide and Mesna finishes, then at 2 hours and 6 hours after the time at the finish of the infusion. All oral Mesna doses should be 40% (w/w) of the <u>f</u><u>inal 24 hour</u> ifosfamide dose rounded down to the nearest whole tablet.</p><p style="text-align:justify">Example dosage schedule:</p><table border="1" align="center" cellspacing="10" cellpadding="10" style="width:500px"><tbody><tr><td style="text-align:center">&nbsp;</td><td rowspan="1" colspan="2" style="text-align:center; width:100px">Day 1</td><td style="text-align:center; width:68px">Day 2</td><td rowspan="1" colspan="2" style="text-align:center; width:133px">Day 3</td><td rowspan="1" colspan="2" style="text-align:center; width:121px">Day 4</td></tr><tr><td style="text-align:center">&nbsp;</td><td style="text-align:center; width:54px">0 hrs</td><td style="text-align:center; width:59px">0-24 hrs</td><td style="text-align:center; width:68px">0-24 hrs</td><td style="text-align:center; width:76px">0-24 hrs</td><td style="text-align:center; width:57px">24 hrs</td><td style="text-align:center; width:61px">26 hrs</td><td style="text-align:center; width:60px">30 hrs</td></tr><tr><td style="text-align:center">Ifosfamide</td><td style="text-align:center; width:54px">-</td><td style="width:59px"><p style="text-align:center">2g/m&sup2; infusion</p></td><td style="text-align:center; width:68px">2g/m&sup2; infusion</td><td style="text-align:center; width:76px">2g/m&sup2; infusion</td><td style="text-align:center; width:57px">-</td><td style="text-align:center; width:61px">-</td><td style="text-align:center; width:60px">-</td></tr><tr><td style="text-align:center">Mesna</td><td style="text-align:center; width:54px">0.4g/m&sup2; iv</td><td style="text-align:center; width:59px">2g/m&sup2; infusion</td><td style="text-align:center; width:68px">2g/m&sup2; infusion</td><td style="text-align:center; width:76px">2g/m&sup2; infusion</td><td style="text-align:center; width:57px">0.8g/m&sup2; po</td><td style="text-align:center; width:61px">0.8g/m&sup2; po</td><td style="text-align:center; width:60px">0.8g/m&sup2; po</td></tr></tbody></table><p>&nbsp;</p><p style="text-align:justify"><u>C</u><u>hildren</u></p><p style="text-align:justify">In children it may be necessary to shorten the interval between doses and/or to increase the number of individual doses. This regime protects children who generally have increased micturition.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Elderly</u></p><p style="text-align:justify">No specific information is available. Clinical trials have included patients over</p><p style="text-align:justify">65 and no adverse reactions specific to this age group have been reported.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>High risk patients</u></p><p style="text-align:justify">Patients who have damaged urothelium from previous treatment with oxazaphosphorines or pelvic irradiation, or who are not adequately protected by Mesna at the standard dose, e.g. patients with case history of urinary tract disease: the dose of 40% of oxazaphosphorine dose should be given at intervals shorter than 4 hours and/or the number of doses increased.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Known hypersensitivity to Mesna or any of the excipients.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong>WARNINGS</strong></p><p style="text-align:justify"><u>Hypersensitivity</u></p><p style="text-align:justify">Hypersensitivity reactions to mesna have been reported following administration of mesna as an uroprotectant. These include various skin and subcutaneous tissue symptoms (see Section 4.8).</p><p style="text-align:justify">In addition, cases of severe bullous and ulcerative skin and mucosal reactions were reported.</p><p style="text-align:justify">In some cases, skin reactions were accompanied by one or more other symptoms, such as fever, cardiovascular symptoms, pulmonary symptoms, haematological abnormalities, nausea, vomiting, pain in the extremities, arthralgia, myalgia, malaise and conjunctivitis (see Section 4.8).</p><p style="text-align:justify">Some reactions have presented as anaphylaxis.</p><p style="text-align:justify">Fever accompanied by, e.g., hypotension but no skin manifestations has also been reported.</p><p style="text-align:justify">Some patients with a history of a reaction have shown positive delayed-type skin test results. However, a negative delayed reaction does not exclude hypersensitivity to mesna. Positive immediate-type skin test reactions have occurred in patients regardless of previous mesna exposure or history of hypersensitivity reactions, and may be related to the concentration of the mesna solution used for testing.</p><p style="text-align:justify">Prescribers should be aware that:</p><ul><li style="text-align:justify">severe as well as minor reactions were reported with the use of mesna in regimens to treat both severe systemic autoimmune disease and malignancy and that mesna should be suspected in any hypersensitivity reaction,</li><li style="text-align:justify">these reactions may occur with first exposure or after several months of exposure and in some cases can be life threatening,</li><li style="text-align:justify">the occurrence and severity of reactions appeared to vary with the dose administered with a tendency to shorter intervals following subsequent exposures,</li><li style="text-align:justify">hypersensitivity reactions to mesna were interpreted to resemble the clinical picture of sepsis and, in patients with autoimmune disorders, resemble an exacerbation of the underlying disease.</li></ul><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Thiol Compounds</u>:</p><p style="text-align:justify">Mesna is a thiol compound, i.e., a sulfhydryl (SH) group-containing organic compound. Thiol compounds show some similarities in their adverse reaction profile, including a potential to elicit severe skin reactions. Examples of drugs that are thiol compounds include amifostine, penicillamine, and captopril.</p><p style="text-align:justify">It is not clear whether patients who experienced an adverse reaction to such a drug are at increased risk for any reactions, or similar reactions, to another thiol compound. However, when considering subsequent use of another thiol</p><p style="text-align:justify">compound in such patients, the possibility of an increased risk should be taken into account.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>PRECAUTIONS</strong></p><p style="text-align:justify">Mesna does not prevent hemorrhagic cystitis in all patients. Patients should be monitored accordingly.</p><p style="text-align:justify">Sufficient urinary output should be maintained, as required for oxazaphosphorine treatment.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>L</u><u>ac</u><u>tose Content</u></p><p style="text-align:justify">Mesna tablets contain lactose. This should be taken into account when using the tablets in patients with lactose intolerance, glucose-galactose malabsorption, or galactose intolerance.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>L</u><u>ab</u><u> </u><u>test interferences</u></p><p style="text-align:justify">Mesna treatment may cause false positive reactions in nitroprusside sodium- based urine tests (including dipstick tests) for ketone bodies. The addition of glacial acetic acid can be used to differentiate between a false positive result (cherry-red color that fades) and a true positive result (red-violet color that intensifies).</p><p style="text-align:justify">Mesna treatment may cause false positive reactions in Tillman&rsquo;s reagent-based urine screening tests for ascorbic acid.</p><p style="text-align:justify">In pharmacokinetics studies in healthy volunteers, serum creatine phosphokinase (CPK) values were lower in samples taken 24 hours after</p><p style="text-align:justify">mesna dosing than in pre-dosing samples. While available data are insufficient to determine the cause of this phenomenon, it might be considered to represent a significant interference with thiol (e.g., N-acetylcysteine) dependent enzymatic CPK tests.</p><p style="text-align:justify">See also Section 4.8 for information on laboratory test abnormalities observed in pharmacokinetic studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">The systemic effects of oxazaphosphorines are not affected by Mesna. In clinical trials it was shown that overdoses of Mesna did not diminish the acute toxicity, subacute toxicity, leucocytic activity, and immunosuppressive efficacy of oxazaphosphorines. Animal studies with ifosfamide and</p><p style="text-align:justify">cyclophosphamide on a variety of tumours, have also demonstrated that Mesna does not interfere with their antineoplastic activity.</p><p style="text-align:justify">Mesna also does not affect the antineoplastic efficacy of other cytostatics (e.g. adriamycin, BCNU, methotrexate, vincristine), nor the therapeutic effect of other drugs such as digitalis glucosides.</p><p style="text-align:justify">Food does not influence the absorption and urinary elimination of Mesna.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">There are no adequate data from the use of mesna in pregnant or lactating women.&nbsp; Physicians should carefully consider the potential risks and benefits for each specific patient before prescribing mesna.</p><p style="text-align:justify">Pregnancy and lactation are contraindications for cytostatic treatment, and consequently Mesna is not likely to be used under these circumstances.</p><p style="text-align:justify">Should an individual patient be undergoing oxazaphosphorine therapy during pregnancy then Mesna should be administered to this patient.</p><p style="text-align:justify">Mothers should not breast-feed whilst being treated with these drugs.</p><p style="text-align:justify">Animal studies have shown no evidence of embryotoxic or teratogenic effects of Mesna<em>.</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Patients undergoing treatment with mesna may experience undesirable effects (including, e.g., syncope, light-headedness, lethargy/drowsiness, dizziness, and blurred vision) which could affect the ability to drive or use machines. The decision to drive or operate machinery should be made on an individual basis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">The most frequently occurring adverse reactions (&gt; 10%) associated with use of mesna are: headache, abdominal pain/colic, light headedness, lethargy/drowsiness, pyrexia, rash, diarrhoea, nausea, flushing, and influenza- like illness.</p><p style="text-align:justify">The most severe adverse reactions associated with use of mesna are:bullous skin reactions, anaphylaxis, and drug rash with eosinophilia and systemic symptoms (DRESS).</p><p style="text-align:justify">Because mesna is used in combination with oxazaphosphorines or oxazaphosphorine-containing combination chemotherapy, it is often difficult to distinguish adverse reactions that may be due to mesna from those caused by concomitantly administered cytotoxic agents.</p><p style="text-align:justify">ADR frequency is based upon the following scale: Very common (&ge;1/10); Common (&ge;1/100 - &lt;1/10), Uncommon (&ge;1/1,000 - &lt;1/100), Rare (&ge;1/10,000 - &lt;1/1,000), Very rare (&lt;1/10,000), Unknown (adverse reactions reported in the post-marketing experience)</p><table border="1" align="left" cellspacing="20" cellpadding="50" style="width:667px"><tbody><tr><td style="width:276px"><p style="text-align:center"><strong>System Organ Class&nbsp;(SOC)</strong></p></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:center"><strong>Adverse Reaction</strong></p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:center"><strong>Frequency</strong></p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><p>BLOOD AND LYMPHATIC SYSTEM DISORDERS</p></td><td style="width:240px"><p>Lymphadenopathy</p></td><td style="width:150px"><p>Common</p></td></tr><tr><td style="width:276px"><p>IMMUNE SYSTEM DISORDERS</p></td><td style="width:240px"><p>Anaphylaxis</p><p>Hypersensitivity</p></td><td style="width:150px"><p>Unknown</p><p>Unknown</p></td></tr><tr><td style="width:276px"><p>METABOLISM AND NUTRITION DISORDERS</p></td><td style="width:240px"><p>Decreased appetite</p><p>Feeling of dehydration</p></td><td style="width:150px"><p>Common</p><p>Common</p></td></tr><tr><td style="width:276px"><p>PSYCHIATRIC DISORDERS</p></td><td style="width:240px"><p>Insomnia</p><p>Nightmare</p></td><td style="width:150px"><p>Common</p><p>Common</p></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>NERVOUS SYSTEM DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Headache</p><p>Light-headedness</p><p>Lethargy/Drowsiness</p><p>Dizziness</p><p>Paresthesia</p><p>Hyperesthesia</p><p>Syncope</p><p>Hypoesthesia</p><p>Disturbance in attention</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Very common</p><p>Very common</p><p>Very common Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><p>EYE DISORDERS</p></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Conjunctivitis</p><p>Photophobia</p><p>Vision blurred</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Common</p><p>Common</p><p>Common</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>CARDIAC DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Palpitations</p><p>Tachycardia</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Common</p><p>Unknown</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>VASCULAR DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Flushing</p><p>Hypotension</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Very common</p><p>Unknown</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>RESPIRATORY, THORACIC, AND MEDIASTINAL DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Nasal congestion</p><p>Cough</p><p>Pleuritic pain</p><p>Dry mouth</p><p>Bronchospasm</p><p>Dyspnea</p><p>Laryngeal discomfort</p><p>Epistaxis</p><p>Respiratory distress</p><p>Hypoxia</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Unknown</p><p>Unknown</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>GASTROINTESTINAL DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Abdominal pain/colic</p><p>Nausea</p><p>Diarrhoea</p><p>Mucosal irritation<sup>1</sup></p><p>Flatulence</p><p>Vomiting</p><p>Burning pain (substernal / epigastric)</p><p>Constipation</p><p>Gingival bleeding</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Very common</p><p>Very common</p><p>Very common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>HEPATOBILIARY DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Transaminases increased</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Common</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>SKIN AND SUBCUTANEOUS TISSUE DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Rash<sup>2</sup></p><p>Pruritus</p><p>Hyperhidrosis</p><p>Erythema multiforme</p><p>Drug rash<sup>3</sup></p><p>Ulcerations and/or bullae/blistering<sup>4</sup></p><p>Angioedema</p><p>Urticaria</p><p>Burning sensation</p><p>Erythema</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Very common</p><p>Common</p><p>Common</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Arthralgia</p><p>Back pain</p><p>Myalgia</p><p>Pain in extremity</p><p>Pain in jaw</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>RENAL AND URINARY DISORDERS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Dysuria</p><p>Acute renal failure</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Common</p><p>Unknown</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>GENERAL DISORDERS AND ADMINISTRATIVE SITE CONDITIONS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Pyrexia</p><p>Influenza-like illness<sup>3</sup></p><p>Rigors</p><p>Fatigue</p><p>Chest pain</p><p>Malaise</p><p>Face oedema</p><p>Oedema peripheral</p><p>Asthenia</p></td></tr></tbody></table></td><td style="width:150px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Very common</p><p>Very common</p><p>Common</p><p>Common</p><p>Common</p><p>Common</p><p>Unknown</p><p>Unknown</p><p>Unknown</p></td></tr></tbody></table></td></tr><tr><td style="width:276px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>INVESTIGATIONS</p></td></tr></tbody></table></td><td style="width:240px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Activated partial thromboplastin time prolonged</p></td></tr></tbody></table></td><td style="width:150px"><p>Unknown</p></td></tr></tbody></table><p>&nbsp;</p><p><br />&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p style="text-align:justify"><sup>1&nbsp;</sup>Oral, rectal</p><p style="text-align:justify"><sup>2&nbsp;</sup>Including nonpruritic, pruritic, erythema/erythematous, eczematous, papular, and/or macular rashes.</p><p style="text-align:justify"><sup>3</sup> mucocutaneous, mucosal, oral, vulvovaginal, anorectal</p><p style="text-align:justify"><sup>4</sup> vesicular, exfoliative, maculo-papular, morbilliform</p><p style="text-align:justify">&nbsp;</p><ul><li style="text-align:justify">Time to onset and experience with re-exposure</li></ul><p style="text-align:justify">In these studies, some subjects experienced their events on first exposure to mesna and others after the second or third exposure. In general, the complete spectrum of symptoms experienced by a subject developed over a period of several hours.</p><p style="text-align:justify">Some subjects experienced no further reactions after their initial event while others experienced an exacerbation of events upon repeated dosing.</p><p style="text-align:justify">&nbsp;</p><ul><li style="text-align:justify">Cutaneous/mucosal reactions</li></ul><p style="text-align:justify">Cutaneous and mucosal reactions were reported to occur after both intravenous and oral mesna. These reactions included rashes, pruritus, flushing, mucosal irritation, pleuritic pain, and conjunctivitis. Approximately one-quarter of subjects with any event experienced cutaneous/mucosal reactions in conjunction with other adverse symptoms, which included, dyspnea, fever, headache, gastrointestinal symptoms, drowsiness, malaise, myalgia, and influenza-like symptoms.</p><p style="text-align:justify">&nbsp;</p><ul><li style="text-align:justify">Gastrointestinal reactions</li></ul><p style="text-align:justify">Gastrointestinal reactions reported in healthy subjects included nausea, vomiting, diarrhoea, abdominal pain/colic, epigastric pain/burning, constipation, and flatulence and were reported to occur after intravenous and oral mesna administration.</p><p style="text-align:justify">&nbsp;</p><ul><li style="text-align:justify">In-vivo effect on lymphocyte counts</li></ul><p style="text-align:justify">In pharmacokinetics studies in healthy volunteers, administration of single doses of mesna was commonly associated with a rapid (within 24 hours) and in some cases marked decrease in lymphocyte count, which was generally reversible within 1 week of administration. Data from studies with repeated dosing over several days are insufficient to characterize the time course of lymphocyte count changes under such conditions.</p><p style="text-align:justify">&nbsp;</p><ul><li style="text-align:justify">In-vivo effect on serum phosphorus levels</li></ul><p style="text-align:justify">In pharmacokinetics studies in healthy volunteers, administration of mesna on single or multiple days was in some cases associated with moderate transient increases in serum phosphorus concentration.</p><p style="text-align:justify">These phenomena should be considered when interpreting laboratory results.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><u>Reporting of suspected adverse reactions</u></p><p style="text-align:justify">Reporting suspected adverse reactions after authorisation of Holoxan is important. It allows continued monitoring of the benefit/risk balance of Holoxan. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system as per following contact details:</p><ul><li style="text-align:justify"><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:520px"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify">-&nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p style="text-align:justify">&nbsp;</p><ul><li style="text-align:justify"><strong>Other GCC States:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:520px"><tbody><tr><td><p style="text-align:justify">Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Reports of inadvertent overdose and observations from a high-dose tolerability study in healthy volunteers showed that, in adults, single doses in the range of approximately 4g to 7g of mesna can cause symptoms such as nausea, vomiting, abdominal pain/colic, diarrhoea, headache, fatigue, limb and joint pains, rash, flushing, hypotension, bradycardia, tachycardia, paresthesia, fever, and bronchospasm.</p><p style="text-align:justify">A markedly increased rate of nausea, vomiting and diarrhoea has also been found in oxazaphosphorine-treated patients receiving &ge; 80 mg mesna per kg per day intravenously compared with patients receiving lower doses or hydration treatment only.</p><p style="text-align:justify">A specific antidote to Mesna is not known.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Mesna is an antidote, and offers the possibility of reliably preventing urotoxic side-effects associated with aggressive cancer chemotherapy using oxazaphosphorine cytostatics. Extensive and wide-ranging pharmacological and toxicological investigations have shown that Mesna has no intrinsic pharmacodynamics and low toxicity. The pharmacological and toxicological inertness of Mesna administered systemically and its excellent detoxifying effect in the efferent urinary tract and bladder, are due to the nature of its pharmacokinetics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Mesna is easily and rapidly transformed by auto-oxidation into its only metabolite mesna-disulphide (dimesna). Dimesna remains in the intravascular compartment and is quickly transported to the kidneys. In the epithelium of renal tubuli, dimesna is reduced to the free thiol compound, which is then able to react chemically in the urine with toxic oxazaphosphorine metabolites.</p><p style="text-align:justify">Following oral administration, absorption occurs in the small intestine. Mean peak concentrations of free thiols in the urine occur between 2-4 hours after dosing. Approximately 25 &plusmn; 10% of the given dose appears as free Mesna in the urine in the first 4 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nothing relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>C</u><u>ore:</u> Lactose monohydrate, microcrystalline cellulose, dibasic calcium phosphate dihydrate, corn starch, povidone K25, magnesium stearate.</p><p style="text-align:justify"><u>F</u><u>ilm-coating (Pharma coat):</u> Hydroxypropylmethylcellulose, polyethylene glycol 6000, titanium dioxide E 171, simethicone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Do not store above 30&ordm;C.</p><p style="text-align:justify">Protected from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Folding box containing blister packs consisting of: aluminium 20 &micro;m (top layer),polyamide 25 &micro;m, aluminium 45 &micro;m, PVC 60 &micro;m (bottom layer).</p><p style="text-align:justify">One blister strip contains 10 tablets. Pack sizes: 10 tablets, 20 tablets, 50 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special instructions necessary.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Oncology GmbH
Kantstraße 2
33790 Halle/Westphalia
Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2014
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>